Literature DB >> 29502916

Inborn Errors of Metabolism with Myopathy: Defects of Fatty Acid Oxidation and the Carnitine Shuttle System.

Areeg El-Gharbawy1, Jerry Vockley2.   

Abstract

Fatty acid oxidation disorders (FAODs) and carnitine shuttling defects are inborn errors of energy metabolism with associated mortality and morbidity due to cardiomyopathy, exercise intolerance, rhabdomyolysis, and liver disease with physiologic stress. Hypoglycemia is characteristically hypoketotic. Lactic acidemia and hyperammonemia may occur during decompensation. Recurrent rhabdomyolysis is debilitating. Expanded newborn screening can detect most of these disorders, allowing early, presymptomatic treatment. Treatment includes avoiding fasting and sustained extraneous exercise and providing high-calorie hydration during illness to prevent lipolysis, and medium-chain triglyceride oil supplementation in long-chain FAODs. Carnitine supplementation may be helpful. However, conventional treatment does not prevent all symptoms.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Carnitine shuttling defects; Fatty acid oxidation defects; Rhabdomyolysis

Mesh:

Substances:

Year:  2017        PMID: 29502916      PMCID: PMC6566095          DOI: 10.1016/j.pcl.2017.11.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  18 in total

Review 1.  Common metabolic disorder (inborn errors of metabolism) concerns in primary care practice.

Authors:  Marisha Agana; Julia Frueh; Manmohan Kamboj; Dilip R Patel; Shibani Kanungo
Journal:  Ann Transl Med       Date:  2018-12

Review 2.  Fatty acid oxidation disorders.

Authors:  J Lawrence Merritt; Marie Norris; Shibani Kanungo
Journal:  Ann Transl Med       Date:  2018-12

3.  Muscle Krüppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis.

Authors:  Liyan Fan; David R Sweet; Domenick A Prosdocimo; Vinesh Vinayachandran; Ernest R Chan; Rongli Zhang; Olga Ilkayeva; Yuan Lu; Komal S Keerthy; Chloe E Booth; Christopher B Newgard; Mukesh K Jain
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

4.  A Case of Carnitine Palmitoyltransferase II Deficiency in Bahrain With a Novel Mutation.

Authors:  Zahra Alsahlawi; Zainab Fadhul; Ali Mahmood; Ali Mohamed; Mohamed Khalil; Emtithal Aljishi
Journal:  Cureus       Date:  2022-06-17

Review 5.  Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease.

Authors:  Judy Baek; Chenchen He; Farsad Afshinnia; George Michailidis; Subramaniam Pennathur
Journal:  Nat Rev Nephrol       Date:  2021-10-06       Impact factor: 42.439

Review 6.  Diagnosis and Clinical Management of Long-chain Fatty-acid Oxidation Disorders: A Review.

Authors:  Joshua J Baker; Barbara K Burton
Journal:  touchREV Endocrinol       Date:  2021-09-10

7.  Pathogenic and rare deleterious variants in multiple genes suggest oligogenic inheritance in recurrent exertional rhabdomyolysis.

Authors:  Nyamkhishig Sambuughin; Ognoon Mungunsukh; Mingqiang Ren; John F Capacchione; Iren Horkayne-Szakaly; Kevin Chuang; Sheila M Muldoon; Jonathan K Smith; Francis G O'Connor; Patricia A Deuster
Journal:  Mol Genet Metab Rep       Date:  2018-08-01

8.  A case report of a mild form of multiple acyl-CoA dehydrogenase deficiency due to compound heterozygous mutations in the ETFA gene.

Authors:  Robin Chautard; Cécile Laroche-Raynaud; Anne-Sophie Lia; Pauline Chazelas; Paco Derouault; Franck Sturtz; Yasser Baaj; Alice Veauville-Merllié; Cécile Acquaviva; Frédéric Favreau; Pierre-Antoine Faye
Journal:  BMC Med Genomics       Date:  2020-01-29       Impact factor: 3.063

9.  Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD).

Authors:  Abbe N Vallejo; Henry J Mroczkowski; Joshua J Michel; Michael Woolford; Harry C Blair; Patricia Griffin; Elizabeth McCracken; Stephanie J Mihalik; Miguel Reyes-Mugica; Jerry Vockley
Journal:  Clin Transl Immunology       Date:  2021-06-27

10.  CR reprograms acetyl-CoA metabolism and induces long-chain acyl-CoA dehydrogenase and CrAT expression.

Authors:  Volha Mezhnina; Ryan Pearce; Allan Poe; Nikkhil Velingkaar; Artem Astafev; Oghogho P Ebeigbe; Kuldeep Makwana; Yana Sandlers; Roman V Kondratov
Journal:  Aging Cell       Date:  2020-10-26       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.